Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Spinoff / Spinout | Alive

About Transgeneron Therapeutics

Transgeneron Therapeutics seeks to develop a new approach to diabetes that has the potential to replace insulin therapy, a multibillion-dollar market.

Transgeneron Therapeutics Headquarters Location

Gainesville, Florida,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Transgeneron Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Transgeneron Therapeutics is included in 1 Expert Collection, including Diabetes.



1,750 items

  • When was Transgeneron Therapeutics founded?

    Transgeneron Therapeutics was founded in 2007.

  • Where is Transgeneron Therapeutics's headquarters?

    Transgeneron Therapeutics's headquarters is located at Gainesville.

  • What is Transgeneron Therapeutics's latest funding round?

    Transgeneron Therapeutics's latest funding round is Spinoff / Spinout.

  • Who are the investors of Transgeneron Therapeutics?

    Investors of Transgeneron Therapeutics include University of Florida.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.